Noopur Liffick
Investor Relations Contact chez CHINOOK THERAPEUTICS, INC.
Profil
Noopur Batsha Liffick is currently the Director at Sairopa B V and the SVP-Investor Relations & Corporate Communications at Chinook Therapeutics, Inc. Previously, she held positions as the Executive Director-IR & Corporate Communications at Aduro BioTech, Inc., Vice President at Gerson Lehrman Group, Inc., and Vice President-Corporate Development at Rezolute, Inc. from 2014 to 2018.
Ms. Liffick has a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of California, Berkeley.
Postes actifs de Noopur Liffick
| Sociétés | Poste | Début |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Investor Relations Contact | 01/10/2020 |
Sairopa B V
 Sairopa B V MiscellaneousMiscellaneous Sairopa B V is a Dutch company that develops medicines and operates as an investment holding company. | Director/Board Member | - |
Anciens postes connus de Noopur Liffick
| Sociétés | Poste | Fin |
|---|---|---|
| REZOLUTE, INC. | Corporate Officer/Principal | 01/10/2018 |
Gerson Lehrman Group, Inc.
 Gerson Lehrman Group, Inc. Miscellaneous Commercial ServicesCommercial Services Gerson Lehrman Group, Inc. provides membership network for learning and expertise. The firm promotes knowledge exchange through conversations, small group convenings, mentorships, surveys, and other interactions with its network of experts. The company was founded by Alexander Saint-Amand, Thomas D. Lehrman, and Mark Gerson in 1998 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/05/2014 |
| CHINOOK THERAPEUTICS, INC. | Investor Relations Contact | - |
Formation de Noopur Liffick
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REZOLUTE, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
Gerson Lehrman Group, Inc.
Gerson Lehrman Group, Inc. Miscellaneous Commercial ServicesCommercial Services Gerson Lehrman Group, Inc. provides membership network for learning and expertise. The firm promotes knowledge exchange through conversations, small group convenings, mentorships, surveys, and other interactions with its network of experts. The company was founded by Alexander Saint-Amand, Thomas D. Lehrman, and Mark Gerson in 1998 and is headquartered in New York, NY. | Commercial Services |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
Sairopa B V
Sairopa B V MiscellaneousMiscellaneous Sairopa B V is a Dutch company that develops medicines and operates as an investment holding company. | Miscellaneous |
